European Tour player Linda Wessberg invests in Pharma Way

We welcome Linda Wessberg as a new shareholder in the company and look forward to following her competitions during the year on the European Tour.

Pharma Way AB carries out a new share issue of SEK 15 million with subscription period until April 30. The new capital will be used to finance the launch of Dot Shot in USA and Europe through e-commerce. During 2020, the Company has established a wholly owned subsidiary in the United States, Pharma Way North America LLC, and made all preparations for the launch of Dot Shot in the United States during April/May 2021.

"Pharma Way's product Dot Shot, which I have been given the opportunity to test and evaluate, is the basis for my decision to invest in the company. I see great potential both from a health perspective and from an economic perspective as the company is now launching its first Dot Shot product on the European and the US market. I have been touring on the 2 biggest professional tours LET and LPGA for almost 18 years and have always been interested in products that can improve my golf, stay free of inflammation and relieve any sensations of exercise pain and joint pain that are common among us golfers, says Linda Wessberg."

DOT SHOT is a well-documented wellness shot based on water-soluble curcumin from turmeric with faster and better effect which provides an increased value for the consumer compared to current products in the Europe and US market.

The US wellness shot market is valued at over USD 450 million and increase by 15-20% annually. The market is expected to continue its strong growth as US consumers look for products that help them improve their overall health and well-being. The market has also benefited from the current Corona pandemic and is expected to continue strong growth in the coming years.

The company will have video meetings on 13/4 and 21/4 at 5 pm CET where we present the company and answer questions. The CEO for Pharma Way North America LLC will also be present. Registration is made to marten.osterlund@pharma-way.com write which meeting date you want to participate and we will send you a link.


Älterer Post Neuerer Post